Rising Awareness of Fatty Liver Disease Among Lean Individuals
Recent studies reveal that fatty liver disease, now termed MASLD, affects many lean individuals, challenging traditional perceptions of liver health.
Approximately 38.6% of Indian adults are estimated to have fatty liver disease.
Fatty liver can occur in individuals with a normal BMI, emphasizing the need for broader health assessments.
Lifestyle changes and medical management are crucial for addressing metabolic dysfunction associated with fatty liver.
A growing number of individuals are discovering they have fatty liver disease despite appearing healthy. This condition, now referred to as metabolic dysfunction-associated steatotic liver disease (MASLD), is increasingly recognized in routine health checks. Patients often express disbelief when informed of their diagnosis, especially if they maintain a healthy lifestyle or have normal liver test results.
Historically, fatty liver was primarily associated with excessive alcohol consumption. However, recent research indicates that it is linked to metabolic issues such as obesity, diabetes, and high cholesterol. A systematic review of studies in India suggests that nearly 4 out of 10 adults may be affected by this condition, highlighting that even those who appear fit may have excess fat accumulating in their livers.
The relationship between obesity and fatty liver is significant, with a meta-analysis showing that about 70% of overweight individuals and 75% of those with obesity have MASLD. Importantly, fatty liver disease can also affect individuals with a normal BMI, indicating that body weight alone is not a reliable indicator of liver health. A global review found that around 40% of people with MASLD were not obese, and nearly 20% were lean, underscoring the need for comprehensive metabolic assessments beyond just weight.
The implications of fatty liver disease extend beyond the liver itself, as it is associated with serious health risks, including cardiovascular disease, type 2 diabetes, and chronic kidney disease. Individuals at higher risk include those with increasing waistlines, prediabetes, or abnormal cholesterol levels. Medical professionals may employ blood tests and imaging techniques to evaluate liver health and fibrosis risk, ensuring that fatty liver is not overlooked as a minor issue.
Fortunately, advancements in managing MASLD have emerged, with lifestyle modifications and targeted medical treatments showing promise in improving liver health. The key takeaway is to view fatty liver not merely as a benign condition but as a critical indicator of broader metabolic health issues. Proactive screening and lifestyle changes can lead to better outcomes, making awareness and early intervention vital for those at risk.
